Cardiac Dimensions
Kirkland, United States · Health Care · 68 employees
Cardiac Dimensions® is a leader in the development of innovative, minimally invasive treatment modalities to address heart failure and associated cardiovascular conditions. The company’s flagship technology, the Carillon Mitral Contour System®, is designed to address functional mitral regurgitation (FMR) using a catheter-based approach. Cardiac Dimensions has operations in Kirkland, Washington, Sy
Funding history
- Series series e — $53.0M — Mar 2025
- Series series d — $35.0M — Jan 2023
Recent signals
- Sep 03, 2025: Cardiac Dimensions Appoints William T. Abraham as Chief Medical Officer
- Mar 20, 2025: Raised $53.0M in Series series e
- Jan 16, 2024: Cardiac Dimensions Appoints Satya Shreenivas, MD as Chief Medical Officer
- Jan 05, 2023: Raised $35.0M in Series series d
See plans & pricing → Track Cardiac Dimensions’s funding, hiring, and signals — with verified contacts — on Fundz.